132 related articles for article (PubMed ID: 11079286)
1. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals.
Bozovich M; Rubino CM; Edmunds J
Pharmacotherapy; 2000 Nov; 20(11):1375-83. PubMed ID: 11079286
[TBL] [Abstract][Full Text] [Related]
2. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
Till LT; Voris JC; Horst JB
J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
[TBL] [Abstract][Full Text] [Related]
3. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.
Mazzolini TA; Irons BK; Schell EC; Seifert CF
J Manag Care Pharm; 2005; 11(9):763-71. PubMed ID: 16300420
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a pharmacist-managed lipid clinic: in-person versus telephone.
Dolder NM; Dolder CR
J Am Pharm Assoc (2003); 2010; 50(3):375-8. PubMed ID: 20452911
[TBL] [Abstract][Full Text] [Related]
5. Does a lipid clinic increase compliance with National Cholesterol Education Program Treatment Guidelines? Report of a case-matched controlled study.
Yates S; Annis L; Pippins J; Walden S
South Med J; 2001 Sep; 94(9):907-9. PubMed ID: 11592752
[TBL] [Abstract][Full Text] [Related]
6. Development of a pharmacist-managed lipid clinic.
Cording MA; Engelbrecht-Zadvorny EB; Pettit BJ; Eastham JH; Sandoval R
Ann Pharmacother; 2002 May; 36(5):892-904. PubMed ID: 11978169
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.
Collins C; Kramer A; O'Day ME; Low MB
Am J Health Syst Pharm; 2006 Sep; 63(18):1723-7. PubMed ID: 16960256
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a pharmacy care management program for veterans with dyslipidemia.
Smith MC; Boldt AS; Walston CM; Zillich AJ
Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745
[TBL] [Abstract][Full Text] [Related]
9. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong.
Lee SS; Cheung PY; Chow MS
J Clin Pharmacol; 2004 Jun; 44(6):632-9. PubMed ID: 15145971
[TBL] [Abstract][Full Text] [Related]
10. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.
Shaffer J; Wexler LF
Arch Intern Med; 1995 Nov; 155(21):2330-5. PubMed ID: 7487258
[TBL] [Abstract][Full Text] [Related]
11. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
12. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
[TBL] [Abstract][Full Text] [Related]
13. 5-year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease.
Whitley HP; Fermo JD; Chumney EC
Pharmacotherapy; 2006 May; 26(5):682-8. PubMed ID: 16637797
[TBL] [Abstract][Full Text] [Related]
14. Active Lipid Management In Coronary Artery Disease (ALMICAD) study.
Khanal S; Obeidat O; Hudson MP; Al-Mallah M; Bloome M; Lu M; Greenbaum AB; Kugelmass AD; Weaver WD
Am J Med; 2007 Aug; 120(8):734.e11-7. PubMed ID: 17679135
[TBL] [Abstract][Full Text] [Related]
15. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
Allison TG; Squires RW; Johnson BD; Gau GT
Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center.
Fabbio KL; Bradley M; Chrymko M
Ann Pharmacother; 2010 Jan; 44(1):50-6. PubMed ID: 20028961
[TBL] [Abstract][Full Text] [Related]
17. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
Pearson TA; Laurora I; Chu H; Kafonek S
Arch Intern Med; 2000 Feb; 160(4):459-67. PubMed ID: 10695686
[TBL] [Abstract][Full Text] [Related]
18. Results from a practice-based lipid clinic model in achieving low density lipoprotein cholesterol goals.
Thomas HD; Maynard C; Wagner GS; Eisenstein EL
N C Med J; 2003; 64(6):263-6. PubMed ID: 14983613
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
Koren MJ; Hunninghake DB;
J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
[TBL] [Abstract][Full Text] [Related]
20. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
